Potential role of T2Candida in the management of empirical antifungal treatment in patients at high risk of candidaemia: a pilot single-centre study | Zendy

Maddalena Giannella | Zendy; Michela Paolucci | Zendy; Greta Roncarati | Zendy; Giacomo Vandi | Zendy; Renato Pascale | Zendy; Filippo Trapani | Zendy; Michele Bartoletti | Zendy; Sara Tedeschi | Zendy; Simone Ambretti | Zendy; Russell E. Lewis | Zendy; Maria Carla Re | Zendy; Pierluigi Viale | Zendy

Open Access

Potential role of T2Candida in the management of empirical antifungal treatment in patients at high risk of candidaemia: a pilot single-centre study

Author(s) -

Maddalena Giannella,

Michela Paolucci,

Greta Roncarati,

Giacomo Vandi,

Renato Pascale,

Filippo Trapani,

Michele Bartoletti,

Sara Tedeschi,

Simone Ambretti,

Russell E. Lewis,

Maria Carla Re,

Pierluigi Viale

Publication year - 2018

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dky247

Subject(s) - antifungal , medicine , intensive care medicine , fluconazole , dermatology

We estimated the diagnostic accuracy of T2Candida, with blood culture (BC) as the gold standard, and compared turnaround time between these two techniques in order to investigate the potential role of T2Candida in the management of empirical antifungal treatment (EAT).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research